Nuveen LLC Invests $442,000 in American Vanguard Corporation $AVD

Key Points

• Nuveen LLC has acquired a new stake in American Vanguard Corporation, purchasing 100,353 shares valued at approximately $442,000, representing around 0.35% of the company.
• Other institutional investors, including Price T Rowe Associates and Wells Fargo, have also increased their holdings, indicating renewed interest in American Vanguard.
• Analysts have mixed ratings on AVD, with one recent downgrade from "buy" to "hold," while the stock maintains a consensus "Buy" rating and an average target price of $12.00.

Nuveen LLC purchased a new stake in American Vanguard Corporation (NYSE:AVD - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 100,353 shares of the basic materials company's stock, valued at approximately $442,000. Nuveen LLC owned 0.35% of American Vanguard as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in AVD. Aigen Investment Management LP acquired a new position in American Vanguard in the 1st quarter worth $44,000. Federated Hermes Inc. acquired a new stake in American Vanguard in the 1st quarter valued at approximately $283,000. Mackenzie Financial Corp raised its position in American Vanguard by 27.2% in the 1st quarter. Mackenzie Financial Corp now owns 130,339 shares of the basic materials company's stock valued at $573,000 after buying an additional 27,896 shares during the last quarter. CWM LLC boosted its position in American Vanguard by 134.7% during the 1st quarter. CWM LLC now owns 9,425 shares of the basic materials company's stock worth $41,000 after acquiring an additional 5,410 shares during the last quarter. Finally, Cerity Partners LLC bought a new position in shares of American Vanguard during the 1st quarter worth approximately $48,000. 79.00% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

AVD has been the topic of a number of research reports. Wall Street Zen raised shares of American Vanguard from a "hold" rating to a "buy" rating in a research report on Friday, September 5th. Lake Street Capital decreased their price objective on American Vanguard from $14.00 to $12.00 and set a "buy" rating for the company in a report on Monday, June 9th. One research analyst has rated the stock with a Buy rating, According to data from MarketBeat, the stock presently has a consensus rating of "Buy" and a consensus price target of $12.00.

American Vanguard Stock Performance

Shares of AVD traded down $0.02 during trading hours on Wednesday, hitting $5.38. The company had a trading volume of 147,670 shares, compared to its average volume of 177,834. The business has a fifty day moving average of $4.56 and a 200-day moving average of $4.39. The company has a quick ratio of 1.00, a current ratio of 1.91 and a debt-to-equity ratio of 0.82. The firm has a market cap of $152.81 million, a price-to-earnings ratio of -1.20 and a beta of 1.26. American Vanguard Corporation has a 12 month low of $3.28 and a 12 month high of $6.68.

American Vanguard (NYSE:AVD - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The basic materials company reported ($0.03) EPS for the quarter, beating analysts' consensus estimates of ($0.11) by $0.08. The business had revenue of $129.31 million for the quarter, compared to analyst estimates of $130.00 million. American Vanguard had a negative net margin of 23.72% and a negative return on equity of 26.21%.

American Vanguard Profile

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.